Ligand Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
09 Nov 22 | SellUS$128,283 | Octavio Espinoza | Individual | 1,696 | US$75.64 | |
16 Sep 22 | SellUS$268,060 | John Higgins | Individual | 3,000 | US$90.00 | |
13 May 22 | BuyUS$206,910 | Matthew Foehr | Individual | 2,500 | US$82.76 |
Insider Trading Volume
Insider Buying: LGND insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 792,173 | 4.7% |
Individual Insiders | 967,524 | 5.7% |
Institutions | 15,133,882 | 89.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,789,479 | $199.3m | 4.65% | no data | |||
1,793,414 | $128.1m | 1.1% | no data | |||
1,262,333 | $90.2m | -9.15% | 0.04% | |||
951,318 | $68.0m | -12.23% | no data | |||
793,621 | $56.7m | 1.24% | 0.05% | |||
483,347 | $34.5m | -1.58% | 2.37% | |||
454,416 | $32.5m | 0.59% | 0.51% | |||
449,118 | $32.1m | 1.45% | 0.01% | |||
442,359 | $31.6m | 3.21% | 0.02% | |||
427,306 | $30.5m | 5.17% | 0.05% | |||
417,695 | $29.8m | 14.07% | no data | |||
319,054 | $22.8m | -30.54% | 1.07% | |||
290,110 | $20.7m | -0.21% | no data | |||
285,634 | $20.4m | -3.72% | 0.98% | |||
234,320 | $16.7m | 27.13% | 0.04% | |||
180,409 | $12.9m | -13.31% | 0.01% | |||
173,113 | $12.4m | -12.22% | no data | |||
166,217 | $11.9m | 109.31% | 0.01% | |||
162,187 | $11.6m | -11.13% | no data | |||
160,577 | $11.5m | 0% | no data | |||
160,534 | $11.5m | -1.26% | no data | |||
144,013 | $10.3m | -4.08% | no data | |||
126,087 | $9.0m | 3.47% | 0.54% | |||
122,571 | $8.8m | 0% | no data | |||
115,000 | $8.2m | 0% | 2.46% |